ONCOBIOLOGICS INC's ticker is ONS and the CUSIP is 68235M105. A total of 15 filers reported holding ONCOBIOLOGICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $29,000 | +16.0% | 29,082 | 0.0% | 0.01% | +150.0% |
| Q2 2018 | $25,000 | -3.8% | 29,082 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $26,000 | -31.6% | 29,082 | 0.0% | 0.00% | -42.9% |
| Q4 2017 | $38,000 | -5.0% | 29,082 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $40,000 | +37.9% | 29,082 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $29,000 | -62.8% | 29,082 | 0.0% | 0.01% | -55.6% |
| Q1 2017 | $78,000 | -11.4% | 29,082 | 0.0% | 0.02% | -45.5% |
| Q4 2016 | $88,000 | -91.6% | 29,082 | -88.1% | 0.03% | -91.6% |
| Q3 2016 | $1,043,000 | +26.0% | 245,391 | +0.8% | 0.39% | -1.5% |
| Q2 2016 | $828,000 | – | 243,391 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,383,971 | $3,266,000 | 0.21% |
| Cormorant Asset Management, LP | 593,883 | $814,000 | 0.14% |
| Avoro Capital Advisors LLC | 683,531 | $936,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 29,082 | $40,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 138,000 | $189,000 | 0.00% |
| Marshall Wace North America L.P. | 261,800 | $262,000 | 0.00% |
| Virtu Financial LLC | 29,123 | $40,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,795 | $16,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 10,000 | $14,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |